Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study-Reference-Cited by-同舟云学术

Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study

Published:2022-01-07 Issue:2 Volume:192 Page:385-399
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Conley Claire C.^ORCID,McIntyre McKenzie,Pensak Nicole A.,Lynce Filipa,Graham Deena,Ismail-Khan Roohi,Lopez Katherine,Vadaparampil Susan T.,O’Neill Suzanne C.

Funder

Lombardi Survivorship Initiative Pilot Grant

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-022-06518-2.pdf

Reference60 articles.

1. Malmgren JA et al (2018) Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010. Breast Cancer Res Treat 167(2):579–590

2. Gennari A et al (2005) Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer 104(8):1742–1750

3. O’Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10:20–29

4. Mariotto AB et al (2017) Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol Prev Biomark 26(6):809–815

5. Chlebowski RT (2013) Changing concepts of hormone receptor-positive advanced breast cancer therapy. Clin Breast Cancer 13(3):159–166

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Having cancer is very expensive”: A qualitative study of patients with ovarian cancer and PARP inhibitor treatment;Gynecologic Oncology;2024-07

2. Adherence to oral anticancer treatments: network and sentiment analysis exploring perceived internal and external determinants in patients with metastatic breast cancer;Supportive Care in Cancer;2024-06-25

3. Iterative Development of an Interactive Website to Support Shared Decision-Making in Metastatic Breast Cancer;Journal of Cancer Education;2024-05-10

4. Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors;Acta Pharmaceutica;2023-12-01

5. Current Management and Future Perspectives of Hormone Receptor–Positive HER2-Negative Advanced Breast Cancer;Seminars in Oncology Nursing;2023-12